ALLMedicine Type 1 Diabetes Center

May 28th, 2020 - We evaluated the impact of flash continuous glucose monitoring (FCGM) on glycemic control and healthcare burden in a large real-world cohort of patients with type 1 diabetes (T1D) initiating FCGM technology. In this retrospective cohort study, we ...

May 28th, 2020 - Ultra rapid lispro (URLi) is a novel insulin lispro formulation developed to more closely match physiological insulin secretion and improve postprandial glucose control. This study compared the pharmacokinetics, glucodynamics, safety, and tolerabi...

May 27th, 2020 - The aim of this study was to investigate differences in clinical features and HLA genotypes between adult-onset and childhood-onset patients with type 1 diabetes in a Chinese population. This study enrolled 716 Han Chinese patients with type 1 dia...

May 27th, 2020 - Younger age at diagnosis of type 1 diabetes (T1D) may affect the clinical course and outcome. We examined whether age at diagnosis was associated with glycemic control and metabolic outcome in young adulthood. This observational study included 105...

May 27th, 2020 - Purpose: We have summarized key studies regarding the assessment of subclinical macroangiopathic target organ damage (TOD) in type 1 diabetes mellitus (T1DM).Results: Although chronic complications resulting from hyperglycemia, in particular macro...

Nov 6th, 2019 - Approximately 1 of every 300 children in the United States has type 1 diabetes mellitus (T1D), and these patients may require anesthetics for a variety of procedures. Perioperative coordination is complex, and attention to perioperative fasting, a...

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

May 7th, 2019 - The American Association of Clinical Endocrinologists (AACE) has created a transculturalized diabetes chronic disease care model that is adapted for patients across a spectrum of ethnicities and cultures. AACE has conducted several transcultural a...

Apr 23rd, 2019 - Type 1 diabetes is a disease characterized by the destruction of insulin-secreting β-cells in the pancreas. Individuals are treated for this disease with lifelong insulin replacement. However, one attractive treatment possibility is to reprogram a...

May 28th, 2020 - We evaluated the impact of flash continuous glucose monitoring (FCGM) on glycemic control and healthcare burden in a large real-world cohort of patients with type 1 diabetes (T1D) initiating FCGM technology. In this retrospective cohort study, we ...

May 28th, 2020 - Ultra rapid lispro (URLi) is a novel insulin lispro formulation developed to more closely match physiological insulin secretion and improve postprandial glucose control. This study compared the pharmacokinetics, glucodynamics, safety, and tolerabi...

May 27th, 2020 - The aim of this study was to investigate differences in clinical features and HLA genotypes between adult-onset and childhood-onset patients with type 1 diabetes in a Chinese population. This study enrolled 716 Han Chinese patients with type 1 dia...

May 27th, 2020 - Younger age at diagnosis of type 1 diabetes (T1D) may affect the clinical course and outcome. We examined whether age at diagnosis was associated with glycemic control and metabolic outcome in young adulthood. This observational study included 105...

May 27th, 2020 - Purpose: We have summarized key studies regarding the assessment of subclinical macroangiopathic target organ damage (TOD) in type 1 diabetes mellitus (T1DM).Results: Although chronic complications resulting from hyperglycemia, in particular macro...

May 19th, 2020 - The risk of death from COVID-19 is significantly increased in people with both main types of diabetes, although this is strongly influenced by age, as well as A1c and obesity, new pre-print data from the UK show. The findings — which have not yet ...

May 18th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The rapid escalation of telemedicine due to COVID-19 is likely to shift paradigms in the way type 1 diabetes care is delivered in the future, rega...

Apr 22nd, 2020 - As concerns about coronavirus deter people from seeking hospital care, endocrinologists and a leading UK charity are calling for general practitioners (GPs) and the public to be aware of the signs and symptoms of type 1 diabetes. Diabetes UK say t...

Apr 12th, 2020 - A retrospective study of patients at a minority-serving, safety-net hospital showed low uptake of diabetes technology among black patients with type 1 diabetes, compared with their white counterparts. The researchers also found lower usage of the ...

Mar 24th, 2020 - Asthma and type 1 diabetes often co-occur in individual children and their family members, new research suggests. Siblings with either condition were at increased risk for the other compared with the general population. However, although individua...